Pyxis Oncology (PYXS) Intangibles (2023 - 2025)
Pyxis Oncology (PYXS) posted quarterly Intangibles of $2.4 million for Q3 2025, down 89.69% year-over-year from $23.6 million in Q3 2024, and down 2.17% quarter-over-quarter from $2.5 million in Q2 2025.
Pyxis Oncology (PYXS) Intangibles (2023 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has reported Intangibles for 3 consecutive years, with $2.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Intangibles fell 89.69% year-over-year to $2.4 million; the TTM figure through Sep 2025 stood at $2.4 million (down 89.69% YoY), while the FY2024 annual figure was $23.9 million, down 2.42% from the prior year.
- Intangibles slipped to $2.4 million in Q3 2025 per PYXS's latest filing, from $2.5 million in the prior quarter.
- Across five years, Intangibles topped out at $24.5 million in Q4 2023 and bottomed at $2.4 million in Q3 2025.
- Historically, Intangibles has averaged $16.6 million across 3 years, with a median of $23.6 million in 2024.
- Annual changes were most pronounced in 2024 — Intangibles gained 5.94% — and 2025, when it plunged 89.69%.
- Pyxis Oncology's Intangibles stood at $24.5 million in 2023, then declined by 2.42% to $23.9 million in 2024, then sank by 89.8% to $2.4 million in 2025.
- Business Quant data shows PYXS's Intangibles at $2.4 million in Q3 2025, $2.5 million in Q2 2025, and $2.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pyxis Oncology | 198.37 Mn | 165.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 23.87 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Jun 30, 2024 | 23.68 Mn |
| Mar 31, 2024 | 23.73 Mn |
| Dec 31, 2023 | 24.46 Mn |
| Sep 30, 2023 | 22.29 Mn |